Susquehanna International Group, LLP Organogenesis Holdings Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$2.42 - $3.24 $11,616 - $15,552	-4,800 Reduced 17.45%	22,700 $64,000
Q2 2024 Aug 15, 2024	BUY	$2.28 - $3.03 $14,363 - $19,089	6,300 Added 29.72%	27,500 $77,000
Q1 2024 May 07, 2024	SELL	$2.61 - $4.49 $7,830 - $13,470	-3,000 Reduced 12.4%	21,200 $60,000
Q4 2023 Feb 14, 2024	BUY	$1.97 - $4.21 $13,987 - $29,891	7,100 Added 41.52%	24,200 $98,000
Q3 2023 Nov 14, 2023	SELL	$2.34 - $4.43 $208,260 - $394,270	-89,000 Reduced 83.88%	17,100 $54,000
Q2 2023 Aug 11, 2023	BUY	$1.9 - $4.3 $1,520 - $3,440	800 Added 0.76%	106,100 $352,000
Q1 2023 May 16, 2023	BUY	$1.89 - $2.93 $199,017 - $308,529	105,300 New	105,300 $224,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $467M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.